Deep Learning-Guided Discovery of Dual Inhibitors of SARS-CoV-2 Entry and 3CL Protease
Molecules · 20.03.2026 · 31 (6) · 1043
DOI: 10.3390/molecules31061043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 20.03.2026. Verfasst von Peng Gao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Therapeutics Development Branch, Division of Preclinical Innovation, National Center for Translational Sciences (NCATS), National Institutes of Healt…. Hauptthemen laut MEDLINE: SARS-CoV-2, Antiviral Agents, Virus Internalization, Deep Learning. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
The rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) underscores the need for antivirals that are resilient to resistance. Current Food and Drug Administration (FDA)-approved therapies primarily target single viral mechanisms, leaving gaps in efficacy. Here, we developed a Deep Learning-based Activity Screening Model (DLASM), which integrates graph convolutional network with machine learning to identify SARS-CoV-2 inhibitors, using experimental 3-chymotrypsin-like (3CL) main protease assay data. The optimized DLASMs virtually screened ~170,000 compounds from diverse in-house collections and yielded novel hits, several of which not only inhibited the 3CL protease but also blocked viral entry by interfering with heparan sulfate-mediated host interactions. These activities were validated through multiple assays, including 3CL enzymatic inhibition, SARS-CoV-2 pseudotyped particle entry, α-synuclein fibril uptake as a proxy for endocytosis, live virus cytopathic effect, heparan sulfate-dependent entry assay, and a 3D human lung mucociliary tissue model. Molecular docking studies elucidated binding modes at the 3CL protease active site, while molecular dynamics simulations provided insights into compound–heparan sulfate interactions. The identified compounds represent early-stage hits with moderate potency that demonstrate dual-mechanism antiviral activity. Together, these findings establish dual-target inhibition as a promising antiviral strategy, offering not only enhanced potency but also reduced risk of resistance. Moreover, our DLASM framework provides a generalizable pipeline for identifying chemically diverse scaffolds and for broader applications beyond SARS-CoV-2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Therapeutics Development Branch, Division of Preclinical Innovation, National Center for Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, MD 20850, USA.
- Texas Biomedical Research Institute, San Antonio, TX 78227, USA.
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
- Early Translation Branch, Division of Preclinical Innovation, National Center for Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, MD 20850, USA.
ORCID-Profile: Peng Gao, Catherine Z Chen, Desarey Morales Vasquez, Luis Martinez-Sobrido, Wei Zheng, Min Shen
Förderung
- NCATS NIH HHS
- National Center for Advancing Translational Sciences
Zitieren
APA
Gao, P., Pavlinov, I., Xu, M., Chen, C. Z., Morales Vasquez, D., Zhang, Q., Ye, Y., Martinez-Sobrido, L., Zheng, W., & Shen, M. (2026). Deep Learning-Guided Discovery of Dual Inhibitors of SARS-CoV-2 Entry and 3CL Protease. Molecules, 31(6), 1043. https://doi.org/10.3390/molecules31061043
Vancouver
Gao P, Pavlinov I, Xu M, Chen CZ, Morales Vasquez D, Zhang Q, et al. Deep Learning-Guided Discovery of Dual Inhibitors of SARS-CoV-2 Entry and 3CL Protease. Molecules. 2026;31(6):1043. doi:10.3390/molecules31061043
BibTeX
@article{Gao2026,
author = {Gao, Peng and Pavlinov, Ivan and Xu, Miao and Chen, Catherine Z and Morales Vasquez, Desarey and Zhang, Qi and Ye, Yihong and Martinez-Sobrido, Luis and Zheng, Wei and Shen, Min},
title = {Deep Learning-Guided Discovery of Dual Inhibitors of SARS-CoV-2 Entry and 3CL Protease},
journal = {Molecules},
year = {2026},
volume = {31},
number = {6},
pages = {1043},
doi = {10.3390/molecules31061043}
}
EUVIMED